<DOC>
	<DOCNO>NCT03010085</DOCNO>
	<brief_summary>Open versus Laparoscopic Left-sided Hepatectomy ( OLLEH ) trial Multi-institutional , prospective randomize trial patient undergoing leave sided hepatectomy laparoscopic versus open procedure . Primary endpoint : Functional recovery Secondary endpoint : Hospital duration , estimate blood loss , operation time , resection margin status , postoperative complication , mortality , liver function laboratory test , re-admission , quality life , cosmesis , cost effectiveness</brief_summary>
	<brief_title>Open Versus Laparoscopic Left-sided Hepatectomy Trial</brief_title>
	<detailed_description>Laparoscopic left-sided hepatectomy widely perform treatment various hepatic neoplasm . Many study report laparoscopic left-sided hepatectomy safe effective compare open conventional left-sided hemihepatectomy . However , prospective study rare randomize controlled trial . The surgeon affiliate medical center capital area Korea launch Open versus Laparoscopic Left-sided Hepatectomy ( OLLEH ) trial verify surgical outcome laparoscopic left-sided hepatectomy . Laparoscopic surgery benefit less wound less pain . The hypothesis study 'The laparoscopic left-sided hemihepatectomy well open surgery functional recovery .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . Patient underwent open laparoscopic leftsided hepatectomy benign malignant neoplasm liver 2 . ChildPugh A without portal hypertension No portosystemic shunt No splenomegaly Platelet count &gt; 100,000/ul 3 . Age 18 80 4 . Eastern Cooperative Oncology Group performance status : 0 1 5 . American society anesthesiology class : I II 6 . Informed consent 1 . Additional intervention liver ( Radio Frequent Ablation , Percutaneous Ethanol . Injection Therapy others ) 2 . Combined hepatectomy 3 . Bile duct reconstruction 4 . Intrahepatic duct stone 5 . Upper abdominal laparotomy history 6 . Previous hepatectomy 7 . Combined operation extrahepatic disease 8 . Vulnerable population ( mental retardation , pregnancy ) 9 . Patient participate clinical trial within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>